ClinicalTrials.govpublic full text
Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older
herpes zoster, herpes zoster vaccine, immunogenicity, subjects 70 years and older, efficacy, safety, adults, vaccine, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848625
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.